MedTrace Logo

Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Cardiac Surgery

NCT05462769 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2022-07-18

No results posted yet for this study

Summary

A single-center prospective study. Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.

Conditions

  • Minimally Invasive Cardiac Surgery

Interventions

DEVICE

Percutaneous vascular closure

Percutaneous arteriotomy closed using a plug-based arteriotomy closure device

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05462769 on ClinicalTrials.gov